The Advancements and Future of Regenerative Medicine

The sector of healthcare is witnessing new advancements in the field of Regenerative Medicine as it aims to provide treatment options for previously considered unsolvable cases. Scientists are seeking ways through stem cell therapy, gene editing, and tissue engineering to restore or replace damaged tissues and organs. Stem cell therapy is a key player by creating tissues from non specialized cells. Tissue engineering and amplification of 3D bioprinting biomaterials allow the production of synthetic organs and therefore lessen the demand for actual organ donors. The use of CRISPR-Cas9 as a gene editing tool opens new opportunities for treating genetic issues such as cystic fibrosis or sickle cell anemia. The main challenge lies in the enormous expenditure, bureaucracy, ethics, and program rejection difficulty. Although these things slow the expansion of the methods to clinics, further deeper studying gives hope for the medicine to fully change the paradigm caring more about curing than relieving symptoms. The funds and innovations that go into regenerative therapies may prove one day to be the answer to millions globally.

Authors

Institutions

Publication Details

Journal
African Journal of Clinical Medicine and Pharmacy Research
Published
2025-04-05
DOI
https://doi.org/10.58578/ajcmpr.v2i2.5330
Primary Topic
Biomedical Ethics and Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Advancements and Future of Regenerative Medicine

Isaac John Umaru, Muhammad Akram, Urooj Rehman
African Journal of Clinical Medicine and Pharmacy Research
Biomedical Ethics and Regulation
article

The Advancements and Future of Regenerative Medicine

Isaac John Umaru, Muhammad Akram, Urooj Rehman
article en

Abstract

The sector of healthcare is witnessing new advancements in the field of Regenerative Medicine as it aims to provide treatment options for previously considered unsolvable cases. Scientists are seeking ways through stem cell therapy, gene editing, and tissue engineering to restore or replace damaged tissues and organs. Stem cell therapy is a key player by creating tissues from non specialized cells. Tissue engineering and amplification of 3D bioprinting biomaterials allow the production of synthetic organs and therefore lessen the demand for actual organ donors. The use of CRISPR-Cas9 as a gene editing tool opens new opportunities for treating genetic issues such as cystic fibrosis or sickle cell anemia. The main challenge lies in the enormous expenditure, bureaucracy, ethics, and program rejection difficulty. Although these things slow the expansion of the methods to clinics, further deeper studying gives hope for the medicine to fully change the paradigm caring more about curing than relieving symptoms. The funds and innovations that go into regenerative therapies may prove one day to be the answer to millions globally.

African Journal of Clinical Medicine and Pharmacy ResearchVol. 2(2)
Government College University, Faisalabad (PK), Kwararafa University (NG), Federal University Wukari
Openalex Percentile: Top 88%
Biomedical Ethics and Regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.